|Staff of the|
Regional Parkinson Center
Paul A. Nausieda, MD –
Medical Director, Research Scientist
Dr. Nausieda is a board-certified neurologist nationally recognized as a
sleep disorders and Parkinson disease specialist. He has written more than 100
publications on the subject of sleep and movement disorders, received many
professional awards, and held numerous academic appointments including
associate professorships in the department of neurological sciences and
pharmacology at Rush University and the Medical College of Wisconsin.
His current practice is one of the largest and most comprehensive in the
country. He is a prominent expert and sought-after lecturer on the
pharmacological treatment of PD. He has been a principal investigator in 40
drug studies of experimental therapeutic agents being tested for FDA approval
and acts as a consultant to a number of pharmaceutical firms involved in the
development of new treatments for Parkinson disease.
Dr. Nausieda’s determination to unveil the cause of PD was the impetus for
his founding the Parkinson Research Institute. He has based his research ideas on the knowledge that he has gained from diagnosing and
treating the disease for more than 40 years. He hopes that the information he
has developed will be a catalyst for both current and future researchers.
Dacy Reimer, APNP/MSN/CCRC –
Advanced Practice Nurse
Practitioner, RPC Coordinator, Brain Procurement
Specialist, Research Scientist
Dacy Reimer is a board-certified nurse practitioner, licensed
to prescribe and treat in primary care and specialized in neurology and
movement disorders. She has had more than 20 years' experience in caring for
individuals with Parkinson disease.
Ms. Reimer was a founding member of PRI, committed to identifying the causes
of PD with a particular interest in disease trait analysis and environmental
effects. She developed the LifeSpan database, a collection of more than 20,000
clinical patient histories and treatments. Ms. Reimer instituted the procedure for
the Parkinson Research Institute Brain Procurement Program, providing 24-hour
clinical service to patients and families wishing to donate brain tissues. She develops and conducts epidemiological research projects. She is co-author of
multiple manuscripts on PD and provides research support to local university
researchers. She is certified as a research coordinator by the Association of
Clinical Research Professionals.
Ms. Reimer has managed more than 20 pharmaceutical studies using experimental
therapeutic agents being tested for FDA approval. She works in collaboration
with Dr. Nausieda as a consultant to a number of pharmaceutical firms involved
in the development of new treatments for Parkinson disease.